Close Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Eshelman Ventures

Investor type Venture Capital
Founders Fred Eshelman

Overview

Unlock datapoints

Portfolio analytics

Team

Investments

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 13
Average round size
info
The average size of a deal this fund participated in
$25M
Portfolio companies 9
Lead investments 4
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.31
Exits 3
Key employees Soon

Areas of investment

  • Biotechnology
  • Medical
  • Therapeutics
  • Health Care
  • Pharmaceutical
Summary

The main office of represented VC is situated in the Wilmington. The fund was located in North America if to be more exact in United States.

Among the most popular portfolio startups of the fund, we may highlight Dignify Therapeutics, Sapience Therapeutics, Sapience Therapeutics. The fund has no exact preference in a number of founders of portfolio startups. When startup sums 3 or 4 of the founder, the probability for it to get the investment is little. For fund there is a match between the location of its establishment and the land of its numerous investments - United States. Besides, a startup needs to be aged 4-5 years to get the investment from the fund. We can highlight the next thriving fund investment areas, such as Developer Platform, Biotechnology.

The typical case for the fund is to invest in rounds with 4-5 participants. Despite the Eshelman Ventures, startups are often financed by Mountain Group Capital, MedImmune Ventures, Hatteras Venture Partners. The meaningful sponsors for the fund in investment in the same round are RA Capital Management, TaiAn Technologies, Mountain Group Capital. In the next rounds fund is usually obtained by Tavistock Life Sciences, TaiAn Technologies, Small Business Innovation Research.

This organization was formed by Fred Eshelman.

Considering the real fund results, this VC is 51 percentage points more often commits exit comparing to other organizations. Comparing to the other companies, this Eshelman Ventures performs on 15 percentage points less the average number of lead investments. The higher amount of exits for fund were in 2017. When the investment is from Eshelman Ventures the average startup value is 10-50 millions dollars. The important activity for fund was in 2015. Despite it in 2019 the fund had an activity. Deals in the range of 10 - 50 millions dollars are the general things for fund. The fund is generally included in less than 2 deals every year.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Eshelman Ventures:
Typical Co-investors
Eshelman Ventures is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Eshelman Ventures:

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Batlivala & Karani Securities India, Maharashtra, Mumbai
Challenjers Capital Beijing, Beijing, China
Coutts England, London, United Kingdom
DHL Bonn, Germany, Nordrhein-Westfalen
Goldmann International GmbH. China, Gansu, Sichuan
Hub One Champagne-Ardenne, France, Tremblay
Hutchison Kinrot HaMerkaz, Israel, Netanya
Indo-US Venture Partners California, Santa Clara, United States
Interactive Technology Holdings China, Hong Kong, Hong Kong Island
Liby Group China, Guangdong, Guangzhou
M10 GmbH Berlin, Berlin, Germany
OSJL LLC -
Reliance Life Insurance India, Maharashtra, Mumbai
SDG Invest -
Shenyang Xunan Technology China, Liaoning, Shenyang
Springboard Ventures Delaware, United States, Wilmington
Taihuoniao Beijing, Beijing, China
The Social Internet Fund New York, New York, United States
Wolsey Ventures Genoa, Italy, Liguria
Yabao Investment Beijing, Beijing, China

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Sapience Therapeutics

Biotechnology
Medical
Therapeutics
$41M31 May 2022 New York, United States

ARC Therapeutics

Biotechnology
Health Care
Pharmaceutical
Therapeutics
$30M31 Mar 2022 Durham, North Carolina, United States

Aravive Biologics

Biotechnology
Clinical Trials
Health Care
$10M03 Jan 2022 Houston, Texas, United States

ARC Therapeutics

Biotechnology
Health Care
Pharmaceutical
Therapeutics
$6M06 Aug 2020 Durham, North Carolina, United States

Kinnate Biopharma

Biopharma
Biotechnology
Health Care
Medical
Therapeutics
$74M19 Dec 2019 San Diego, California, United States

Aruna Biomedical

Biotechnology
Medical
Medical Device
$13M24 Jul 2019 Athens, Georgia, United States

Kinnate Biopharma

Biopharma
Biotechnology
Health Care
Medical
Therapeutics
$22M01 Apr 2018 San Diego, California, United States

Sapience Therapeutics

Biotechnology
Medical
Therapeutics
$22M12 Jul 2016 New York, United States

G1 Therapeutics

Biotechnology
Developer Platform
Medical
Therapeutics
$47M11 May 2016 Durham, North Carolina, United States

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Eshelman Ventures?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

Wait!
You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: